Cambridge ’s Ironwood Pharmaceuticals to split into two businesses
Cambridge-based Ironwood Pharmaceuticals said Tuesday that it plans to separate into two publicly-traded companies, one focused on the company ’s commercial business of gastrointestinal drugs, and the other focused on developing treatments for rare disorders and other serious conditions.
Ironwood (Nasdaq: IRWD) said that both businesses would be headquartered in Cambridge. A spokesperson did not immediately respond to a request for comm ent on how many of the company’s 730 employees globally would…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Max Stendahl Source Type: news